Information  X 
Enter a valid email address

Byotrol PLC (BYOT)

  Print          Annual reports

Friday 25 September, 2020

Byotrol PLC

Director Dealing

RNS Number : 0622A
Byotrol PLC
25 September 2020
 

 

 

 

 

 

 

Byotrol plc ("Byotrol or the Company")

 

Director Dealing

 

 

 

Byotrol plc, the AIM-quoted anti-microbial technology company, is pleased to announce that the Company was notified on 24 September 2020 that on that same day, Nic Hellyer, CFO of the Company, purchased 129,870 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 7.7p per Ordinary Share (the "Purchase").

Following the Purchase, Mr. Hellyer has an interest in 629,870 Ordinary Shares representing 0.0014% of the total voting rights of the Company.

 

 

 

Enquiries:

 

Byotrol plc 

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer  01925 742 000

 

finnCap

Geoff Nash/Kate Bannatyne - Corporate Finance    020 7220 0500

Richard Chambers - ECM

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon     020 7129 1474

[email protected]

 

  This announcement is released by Byotrol plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nic Hellyer

2. 

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

129,870 Ordinary Shares at 7.7p

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

24 September 2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZGZLVDGGGZM

a d v e r t i s e m e n t